Immunoreactive Transforming Growth Factor β‐1, Its Receptor, bcl‐2 Protein, and p53 Protein in Colorectal Adenomas
- 1 October 1997
- journal article
- Published by Wiley in Digestive Endoscopy
- Vol. 9 (4) , 272-277
- https://doi.org/10.1111/j.1443-1661.1997.tb00500.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancerGastroenterology, 1997
- High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progressionGastroenterology, 1996
- Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-β ReceptorsJournal of Biological Chemistry, 1995
- bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomasHuman Pathology, 1995
- Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinomaSurgery Today, 1994
- Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinomaThe Lancet, 1992
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences, 1991
- p53 in colorectal cancer: clinicopathological correlation and prognostic significanceBritish Journal of Cancer, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- A genetic model for colorectal tumorigenesisCell, 1990